Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Biosensis Pty Ltd works in Biotechnology Research, out of Thebarton, South Australia. It is privately held, and its site is biosensis.com. It holds one address on record, all in Australia. Headcount on record is 15. Its work is tagged neurology, neuroscience and cancer research. One Australian registration (ABN) is a confirmed match. The record links nine similar brands, most of them in Biotechnology Research.
ABN93103335959
| BIOSENSIS PTY LTD | ABN 93103335959 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Biosensis specializes in antibodies and reagents for Neuroscience. Our neuroscience portfolio includes products for research in neurodegenerative diseases, neurodevelopment,and neuro-metabolism. Areas of focus include Alzheimer's, Parkinson's and ALS diseases, as well as autophagy and metabolic and stress disorders including metabolic syndrome research, obesity, and neuroimmunology and inflammation with particular emphasis on neurotrophins and neurotrophin receptors for which Biosensis has been the worldwide leader and OEM supplier for more than 30 years.
Biosensis also offers more than 200 high-quality ELISA kits for a wide range of protein targets. Our assays are validated for a variety of sample matrices and where possible, tested by independent research laboratories. Our ELISA kits are complete, ready-to-use and without the need for additional reagents, buffers or plates. Plus our strip format allows you to only use what you need! Our detailed protocols include extensive information about sample preparation, assay execution, data analysis and validation. Full technical support is also provided by our highly skilled technical team at biospeak@biosensis.com.
Our new range of RapidTM ELISA assays can be performed in less than 4 hours without compromising on accuracy, specificity and sensitivity. These assays target potential biomarkers, such as oligomeric Aβ peptides (Alzheimer's Disease, AD), mature BDNF (psychiatric disorders), proNGF (cancer) and p75NTR/NGFR (Amytrophic Lateral Sclerosis, ALS).
Why purchase from Biosensis?
Biosensis is a company formed by a team of life scientists and business people dedicated to the support of researchers in academia and industry worldwide. The team has a combined total of over 50 years experience in the commercialization of life science reagents for the life science research and diagnostic markets. We are therefore able to offer a level of customer support and expertise unmatched in the neuroscience reagent industry.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
One South Australia entity on the ABR: BIOSENSIS PTY LTD (ABN 93 103 335 959), high confidence.
15 counted staff profiles at January 2026, inside the self-reported 11–50 band.
One address on record, Australia only. Primary: 51 West Thebarton Rd, Thebarton, South Australia 5031.
None linked to this brand.
20 tags on the brand's own list, among them neurology, neuroscience and cancer research.
11 profiles list Biosensis Pty Ltd as a peer — 84th percentile in Biotechnology Research. It lists ten peers of its own. TGR BioSciences and Sementis Ltd list it back.